Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Dimitrios, Tryfonopoulos"'
Autor:
Dionysia N. Zouki, Vasiliki‐Elpida Kardara, Stephanie Ioannou, Eleni Arvanitou, Konstantinos Exarchos, Konstantinos Gkikas, Stefanos Konstantoudakis, Sophocles Lanitis, Stylianos Benakis, Dimitrios Tryfonopoulos
Publikováno v:
Clinical Case Reports, Vol 12, Iss 7, Pp n/a-n/a (2024)
Key Clinical Message There is no consensus regarding the therapeutic approach of breast neuroendocrine carcinomas (NECs). As most NECs are hormone receptor positive and HER‐2 negative, we suggest that endocrine‐based strategies may play a leading
Externí odkaz:
https://doaj.org/article/712080110b974ff48f2835708d723288
Autor:
Ioannis K. Gallos, Dimitrios Tryfonopoulos, Gidi Shani, Angelos Amditis, Hossam Haick, Dimitra D. Dionysiou
Publikováno v:
Diagnostics, Vol 13, Iss 24, p 3673 (2023)
Early detection of colorectal cancer is crucial for improving outcomes and reducing mortality. While there is strong evidence of effectiveness, currently adopted screening methods present several shortcomings which negatively impact the detection of
Externí odkaz:
https://doaj.org/article/f52a155623a542de9448a84a5b5273f1
Autor:
Alexandros Ioannou, Georgios Papaxoinis, Dimitrios Dimitroulopoulos, Dimitrios Tryfonopoulos, Panagiotis Gouveris
Publikováno v:
Forum of Clinical Oncology, Vol 12, Iss 3, Pp 28-33 (2022)
Cancer immunotherapy is an emerging beneficial treatment for cancer that acts by activating the immune system to produce antitumour effects. In particular, immune checkpoint therapy has recently provided novel strategies for cancer treatments. Nevert
Externí odkaz:
https://doaj.org/article/1e1379852e644e1a817bbbdbf8316d50
Autor:
Panagiotis Gouveris, Dionysia N. Zouki, Evangelos G. Sarris, Likourgos Kolilekas, Dimitrios Tryfonopoulos, George Papaxoinis, Stamatina Demiri
Publikováno v:
Case Reports in Oncology, Vol 14, Iss 2, Pp 1059-1065 (2021)
Sarcoidosis and sarcoid-like reactions have been associated with many solid tumors including malignant melanoma. There are reports of melanoma patients who develop sarcoidosis without having received any antineoplastic treatment, but there are also m
Externí odkaz:
https://doaj.org/article/5ad169187ad142b88969ff608d2afcb6
Autor:
Nikolaos Mitsimponas, Evangelia Klouva, Dimitrios Tryfonopoulos, Anastasios Grivas, Stamatina Demiri, George Koumakis, Panagiotis Gouveris
Publikováno v:
Case Reports in Oncology, Vol 11, Iss 2, Pp 557-561 (2018)
Aromatase inhibitors (AIs) are a commonly used antihormonal therapy in the treatment of breast cancer in postmenopausal women, specifically in the treatment of hormone receptor-positive breast cancer. AI-associated tendinopathy and muscle tendon rupt
Externí odkaz:
https://doaj.org/article/b54a6b0d80924952b94f06131a92770c
Autor:
Giuseppe Gullo, Alex J. Eustace, Alexandra Canonici, Denis M. Collins, Michael J. Kennedy, Liam Grogan, Oscar Breathhnach, John McCaffrey, Maccon Keane, Michael J. Martin, Rajnish Gupta, Gregory Leonard, Miriam O’Connor, Paula M. Calvert, Paul Donnellan, Janice Walshe, Enda McDermott, Kathleen Scott, Andres Hernando, Imelda Parker, David W. Murray, Alice C. O’Farrell, Ashwini Maratha, Patrick Dicker, Mairin Rafferty, Verena Murphy, Norma O’Donovan, William M. Gallagher, Bonnie Ky, Dimitrios Tryfonopoulos, Brian Moulton, Annette T. Byrne, John Crown
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 11 (2019)
Background: Combining bevacizumab and chemotherapy produced superior response rates compared with chemotherapy alone in metastatic breast cancer. As bevacizumab may cause hypertension (HTN) and increase the risk of cardiac failure, we performed a pil
Externí odkaz:
https://doaj.org/article/dd373e9d21d44deea251f3cc0cedb80b
Autor:
ANGELA APESSOS, KONSTANTINOS AGIANNITOPOULOS, GEORGIA PEPE, GEORGIOS N. TSAOUSIS, PANAGIOTA PITTA, CHRYSANTHI BILI, LINA FLORENTIN, EMMANOUEL SALOUSTROS, ELEFTHERIOS KAMPLETSAS, DIMITRIOS TRYFONOPOULOS, NIKOLAOS TSOUKALAS, EVANGELOS BOURNAKIS, FLORA ZAGOURI, ATHANASSIOS KOTSAKIS, ANNA KOUMARIANOU, IPPOKRATIS KORANTZIS, IOANNIS BOUKOVINAS, GEORGE LYPAS, GEORGIOS FOUNTZILAS, VASILIKI MICHALAKI, SPYRIDON XYNOGALOS, HELENA LINARDOU, EIRINI PAPADOPOULOU, GEORGE NASIOULAS, VASSILIS GEORGOULIAS
Publikováno v:
Anticancer research. 42(12)
Male breast cancer (MBC) is a very rare disorder affecting approximately 1 in 833 men. Genetic predisposition is one of the most important risk factors of MBC with BRCA2 being the most commonly mutated gene in males diagnosed with breast cancer. Howe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a852445b90d523e02fa54397b3d744e8
https://pubmed.ncbi.nlm.nih.gov/36456130
https://pubmed.ncbi.nlm.nih.gov/36456130
Autor:
Georgia-Angeliki Koliou, Kyriaki Papadopoulou, George Pentheroudakis, Elissavet Pazarli, Thomas Makatsoris, George Fountzilas, George Zarkavelis, Gerasimos Aravantinos, Dimitrios Tryfonopoulos, Anna Tsipoura, Epaminontas Samantas, Davide Mauri, Mattheos Bobos, Dimitrios Pectasides, Anna Batistatou, Amanda Psyrri, Constantina Petraki
Publikováno v:
Acta Oncologica. 60:785-793
Gastric cancer is the fifth most common neoplasm worldwide with high rates of mortality. Afatinib, a low molecular, irreversible potent inhibitor of ErbB trans-membrane receptor family, has shown promising results according to preclinical and phase I
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::050e7b48174000dee2f06533b035f236
https://doi.org/10.1080/0284186x.2021.1912822
https://doi.org/10.1080/0284186x.2021.1912822
Autor:
Serafeim Chlapoutakis, Vasiliki Georgakopoulou, Nikolaos Trakas, Georgios Kouvelos, Petros Papalexis, Christos Damaskos, Pagona Sklapani, Anastasios Grivas, Panagiotis Gouveris, Dimitrios Tryfonopoulos, Alexandros Tzovaras, Gerasimos Ardavanis‑Loukeris, Elissavet Grouzi, Demetrios Spandidos, Miltiadis Matsagkas
Publikováno v:
Oncology Letters. 23
Pulmonary embolism (PE), along with deep vein thrombosis, are collectively known as venous thromboembolism (VTE). Predisposing factors for PE include post-operative conditions, pregnancy, cancer and an advanced age; of note, a number of genetic mutat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a05469c90b5a9b582083f3bf2832ee6b
https://doi.org/10.3892/ol.2022.13288
https://doi.org/10.3892/ol.2022.13288
Autor:
Kyriaki Manousou, Angeliki Delimitsou, Paraskevi Apostolou, G. Fountzilas, Drakoulis Yannoukakos, Christos Christodoulou, Florentia Fostira, Andromahi Vagena, Christos Papadimitriou, Dimitrios Tryfonopoulos, Irene Konstantopoulou, Elena Fountzilas, Myrto Papamentzelopoulou
Publikováno v:
Clinical Breast Cancer. 20:152-159
BRCA1/BRCA2 mutation carriers indefinitely comprise a distinct group of patients with breast cancer (BC), with their tumors displaying specific pathologic characteristics. Although these connections are known, they are not fully elucidated. We theref
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::449e12653c04d7ce93cf9118a7f842d8
https://doi.org/10.1016/j.clbc.2019.08.003
https://doi.org/10.1016/j.clbc.2019.08.003